kth.sePublications KTH
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors
Show others and affiliations
2017 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 114, no 12, p. E2293-E2302Article in journal (Refereed) Published
Abstract [en]

Organ-on-a-chip systems areminiaturizedmicrofluidic 3D human tissue and organ models designed to recapitulate the important biological and physiological parameters of their in vivo counterparts. They have recently emerged as a viable platform for personalized medicine and drug screening. These in vitro models, featuring biomimetic compositions, architectures, and functions, are expected to replace the conventional planar, static cell cultures and bridge the gap between the currently used preclinical animal models and the human body. Multiple organoid models may be further connected together through the microfluidics in a similar manner in which they are arranged in vivo, providing the capability to analyze multiorgan interactions. Although a wide variety of human organ-on-a-chip models have been created, there are limited efforts on the integration of multisensor systems. However, in situ continual measuring is critical in precise assessment of the microenvironment parameters and the dynamic responses of the organs to pharmaceutical compounds over extended periods of time. In addition, automated and noninvasive capability is strongly desired for long-term monitoring. Here, we report a fully integrated modular physical, biochemical, and optical sensing platform through a fluidics-routing breadboard, which operates organ-on-a-chip units in a continual, dynamic, and automated manner.We believe that this platform technology has paved a potential avenue to promote the performance of current organ-on-a-chip models in drug screening by integrating a multitude of real-time sensors to achieve automated in situ monitoring of biophysical and biochemical parameters.

Place, publisher, year, edition, pages
National Academy of Sciences , 2017. Vol. 114, no 12, p. E2293-E2302
National Category
Medical Biotechnology
Identifiers
URN: urn:nbn:se:kth:diva-290816DOI: 10.1073/pnas.1612906114ISI: 000396893600007PubMedID: 28265064Scopus ID: 2-s2.0-85016119264OAI: oai:DiVA.org:kth-290816DiVA, id: diva2:1530777
Note

QC 20210226

Available from: 2021-02-24 Created: 2021-02-24 Last updated: 2026-05-07Bibliographically approved
In thesis
1. From DNA Detection to Organs-on-Chip Monitoring: Fabrication Solutions for Integrated Biosensing
Open this publication in new window or tab >>From DNA Detection to Organs-on-Chip Monitoring: Fabrication Solutions for Integrated Biosensing
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Bringing a biosensor from laboratory demonstration to practical use depends as much on fabrication as on the sensing principle itself. This thesis develops fabrication strategies that overcome specific technological barriers across biosensing domains: from single-molecule electrochemical detection to real-time optical monitoring in organ-on-chip platforms.

In the electrochemical domain, the thesis identifies the conditions under which metal-assisted chemical etching enters the self-limiting regime in ultrathin silicon-on-insulator membranes, where catalyst size decouples from pore size, yielding ~5 nm pores with 1 nm variability (Papers I, II). A complementary approach translates micrometer-scale lithographic features into sub-10 nm pores through controlled fracture of pre-stressed membranes, validated for both electrical and optical single-molecule DNA detection down to 30 bases (Paper III). A two-tier fabrication architecture for organic electrochemical transistors decouples electrode routing from polymer channel definition via direct femtosecond laser writing, achieving single-micrometer resolution outside the cleanroom; channel outlining confines the ion-transport volume and improves switching speed by three orders of magnitude (Paper V). Colloidal self-assembly of polystyrene beads in silk fibroin produces biocompatible photonic crystals in which the defect-layer bead diameter programs the passband wavelength, establishing a design principle for spectral control in biocompatible optical structures (Paper IV). This fabrication logic, using particle size to define a functional feature in a host material, extends from the silicon nanopore work and enables the design of biocompatible photonic crystals.

In the optical integration domain, laser-machined PMMA modules with commodity optoelectronics replace benchtop instruments for continuous pH and dissolved oxygen monitoring in microfluidic systems (Paper VI). The modular architecture integrates with the bioreactor design without modification and operates autonomously from single-bioreactor cell culture through five-day multi-organ drug testing, enabling detection of liver-mediated drug conversion that is unobservable in single-organ systems (Paper VII).

Across those domains, understanding the sensing principle, material properties, and available fabrication tools guides the development of processes that achieve application-relevant precision while reducing costs and infrastructure requirements.

Abstract [sv]

Att ta en biosensor från laboratoriedemonstration till praktisk användning beror lika mycket på tillverkning som på sensorprincipen i sig. Denna avhandling utvecklar tillverkningsstrategier som övervinner specifika tekniska hinder inom biosensordomäner: från elektrokemisk detektering av enskilda molekyler till optisk realtidsövervakning i organ-på-chip-plattformar.

Inom den elektrokemiska domänen identifierar avhandlingen de förhållanden under vilka metallassisterad kemisk etsning övergår till ett självbegränsande regime i ultratunna kisel-på-isolator-membran, där katalysatorstorleken frikopplas från porstorleken och ger ~5 nm porer med 1 nm variabilitet (Artikel I, II). En kompletterande metod översätter litografiska strukturer på mikrometerskala till porer under 10 nm genom kontrollerad fraktur av förspända membran, validerad för både elektrisk och optisk detektion av enskilda DNA-molekyler ned till 30 baser (Artikel III). En tvånivå-tillverkningsarkitektur för organiska elektrokemiska transistorer frikopplar elektrodledningar från polymerkanalsdefinition via direkt femtosekundslaserskrivning och uppnår upplösning på enstaka mikrometer utanför renrummet; kanalkonturering begränser jontransportvolymen och förbättrar switchhastigheten med tre storleksordningar (Artikel V). Kolloidal självorganisering av polystyrenkulor i silkesfibroin ger biokompatibla fotoniska kristaller där kuldiametern i defektlagret programmerar passbandsvåglängden och etablerar en designprincip för spektral styrning i biokompatibla optiska strukturer (Artikel IV). Denna tillverkningslogik, att använda partikelstorleken för att definiera en funktionell egenskap i ett värdmaterial, utgår från arbetet med kiselnanoporer och möjliggör design av biokompatibla fotoniska kristaller.

Inom den optiska integrationsdomänen ersätter laserskurna PMMA-moduler med standardkomponenter inom optoelektronik bänkinstrument för kontinuerlig pH- och syreövervakning i mikrofluidiska system (Artikel VI). Den modulära arkitekturen integreras i bioreaktordesignen utan modifikationer och arbetar autonomt från cellodling i enskilda bioreaktorer till femdagars läkemedelstestning i flerorgansystem, vilket möjliggör detektering av leverförmedlad läkemedelsomvandling som inte är observerbar i enkelorgansystem (Artikel VII).

Inom dessa domäner vägleder förståelsen av sensorprincipen, materialegenskaperna och de tillgängliga tillverkningsverktygen utvecklingen av processer som uppnår applikationsrelevant precision med minskade kostnader och infrastrukturkrav.

Abstract [it]

Il passaggio di un biosensore dalla fase di dimostrazione in laboratorio all'uso pratico dipende tanto dal processo di fabbricazione quanto dal principio stesso di rilevamento. Questa tesi sviluppa strategie di fabbricazione volte a superare specifiche barriere tecnologiche in quattro ambiti: dal rilevamento elettrochimico di una singola molecola al monitoraggio ottico in tempo reale nelle piattaforme «organ-on-chip» (organi-su-chip).

La prima parte riguarda i nanopori: minuscoli fori in una membrana di silicio, talmente piccoli che una singola molecola di DNA li occupa quasi interamente. Facendo passare la molecola attraverso il poro, è possibile identificarla. Produrre fori di questa dimensione, pochi miliardesimi di metro, è una sfida tecnologica che oggi richiede strumenti costosi e operatori specializzati. Questa tesi mostra come, sfruttando un fenomeno chimico autolimitante finora non riportato in letteratura, sia possibile fabbricare questi fori in parallelo su larga scala.

La seconda parte è dedicata ai cristalli fotonici biocompatibili, strutture capaci di manipolare la luce e realizzate con materiali compatibili con l'organismo umano, come la seta. La tesi mostra un metodo per introdurre nanostrutture all’interno della seta che permettono di scegliere la lunghezza d’onda della luce trasmessa, aprendo la strada a sensori ottici impiantabili.

La terza parte è dedicata ai transistor elettrochimici organici, dispositivi che permettono di misurare molecole come il glucosio o componenti del sudore, e che potrebbero contribuire alla prossima generazione di sensori indossabili a basso costo. Per definire le geometrie di questi sensori, è solitamente necessario ricorrere all’uso di una camera bianca. Questa tesi presenta una tecnica basata sulla scrittura laser che raggiunge la stessa precisione, ma al di fuori della camera bianca.

L'ultima parte è dedicata agli organi-su-chip, piattaforme miniaturizzate dove cellule umane vengono coltivate per ricreare il funzionamento di tessuti ed organi. Queste piattaforme potrebbero ridurre il ricorso alla sperimentazione animale per testare nuovi farmaci. La tesi sviluppa un sensore ottico a basso costo, in grado di monitorare in tempo reale le funzioni vitali delle cellule, tramite parametri come il pH e l'ossigeno.

Il filo conduttore di tutto il lavoro è uno: comprendere a fondo il principio fisico del sensore, le proprietà dei materiali, e le possibilità degli strumenti a disposizione. Questa comprensione permette di sviluppare processi di fabbricazione più semplici, più economici, e più pronti a uscire dal laboratorio rispetto agli approcci tradizionali.

Place, publisher, year, edition, pages
KTH Royal Institute of Technology, 2026. p. 87
Series
TRITA-EECS-AVL ; 2026:35
National Category
Nanotechnology Nanotechnology for/in Life Science and Medicine
Identifiers
urn:nbn:se:kth:diva-381000 (URN)978-91-8106-585-5 (ISBN)
Public defence
2026-06-09, https://kth-se.zoom.us/j/63919672218, F3, Lindstedtsvägen 26, Stockholm, 10:00 (English)
Opponent
Supervisors
Note

QC 20260507

Available from: 2026-05-08 Created: 2026-05-07 Last updated: 2026-05-12Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

De Ferrari, Fabio

Search in DiVA

By author/editor
De Ferrari, Fabio
In the same journal
Proceedings of the National Academy of Sciences of the United States of America
Medical Biotechnology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 238 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf